Cost‑effectiveness Analysis of Helicobacter pylori Eradication Therapy in First-Degree Relatives of Patients with Gastric Cancer

BACKGROUND: Helicobacter pylori (H. pylori) eradication therapy has been shown to reduce the risk of gastric cancer in patients who have a family history of gastric cancer in first-degree relatives. The aim of this study was to assess the cost-effectiveness of H. pylori eradication therapy in a sele...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Hanrui, Xie, Qian, Zhan, Mei, Jin, Chaohui, Li, Qiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837576/
https://www.ncbi.nlm.nih.gov/pubmed/33519193
http://dx.doi.org/10.2147/PPA.S286860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837576/
https://www.ncbi.nlm.nih.gov/pubmed/33519193
http://dx.doi.org/10.2147/PPA.S286860

Ejemplares similares